Metabolic Diseases of Muscle

FDA OKs Lifesaving Treatment for Pompe Disease

TUCSON, Ariz., April 28, 2006 — The Food and Drug Administration today announced approval of Myozyme, a new treatment for patients with Pompe disease, a rare genetic disorder also known as acid maltase enzyme deficiency.

Pages

MDA in Your Community